Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Head of Investor Relations
Jagsonpal Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Sonia Chajal is recorded as Head of Investor Relations at Jagsonpal Pharmaceuticals Limited. Sonia Chajal has spoken on 2 earnings calls across 1 company, most recently for Jagsonpal Pharmaceuticals Limited on October 29, 2026. Jagsonpal Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“Good day, everyone, and welcome to Q2 and H1 FY27 Earnings Con Call of Jacksonville Pharmaceuticals Limited. We have on call with us Mr. Manish Gupta, Managing Director, Mr. Amrut Medhikar, Chief Operating Officer, and Mr. Nirav Vora, Chief Financial Officer.”
“Good evening, everyone, and welcome to Q4 and FI26 Earnings Conference Call of Jacksonville Pharmaceuticals Limited. We have on call with us Mr. Manish Gupta, Managing Director, Mr. Amrit Medhikar, Chief Operating Officer, and Mr. Nira Bora, Chief Financial Officer.”
Jagsonpal Pharmaceuticals Limited
Head of Investor Relations
Transcript header (unverified)
Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
Earnings Call
Jagsonpal Pharmaceuticals Limited
Earnings Call
Jagsonpal Pharmaceuticals Limited